TE_161
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | AluSg |
---|---|
TE superfamily | Alu |
TE class | SINE |
Gene | NBPF1, - |
Class | Chimeric, Intergenic |
Coding | Non-coding, Other |
Tumor-specific score | 0.38 |
Counts of samples | TCGA_tumor:165; TCGA_normal:5; GTEx:482 |
TSS | chr1(-):16584700 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_161.1 | NBPF1 | Chimeric | Other | MLRNERQFKEEKLAEQLKQAEELRQYKVLVHSQERELTQLREKLREGRDASCSLNQHLQALLTPDEPDKSQGQDLQEQLAEGCRLAQHLVQKLSPENDNDDDEDVQVEVAEKVQKSSAPREMPKAEEKEVPEDSLEECAITCSNSHGPYDSNQPHRKTKITFEEDKVDSTLIGSSSHVEWEDAVHIIPENESDDEEEEEKGPVSPRNLQESEEEEVPQESWDEGYSTLSIPPEMLASYKSYSGTFHSLEEQQVCMAVDIGGHRWDQVKKEDQEATGPRLSRELLDEKGPEVLQDSLDRCYSTPSGYLELTDSCQPYRSAFYILEQQRVGWALDMDEIEKYQEVEEDQDPSCPRLSRELLEAVEPEVLQDSLDRCYSTPSSCLEQPDSCLPYGSSFYALEEKHVGFSLDVGEIEKKGKGKKRRGRRSTKKRRRRGRKEGEEDQNPPCPRLSGMLM | chr1(-):16564166,16564186,16564807,16564918,16565633,16565805,16566408,16566459,16567179,16567351,16567979,16568030,16569073,16569236,16573142,16573193,16574487,16574692,16575157,16575229,16576267,16576481,16577317,16578229,16584513,16584701 |
teRNA_161.2 | NBPF1 | Chimeric | Other | MLRNERQFKEEKLAEQLKQAEELRQYKVLVHSQERELTQLREKLREGRDASCSLNQHLQALLTPDEPDKSQGQDLQEQLAEGCRLAQHLVQKLSPENDNDDDEDVQVEVAEKVQKSSAPREMPKAEEKEVPEDSLEECAITCSNSHGPYDSNQPHRKTKITFEEDKVDSTLIGSSSHVEWEDAVHIIPENESDDEEEEEKGPVSPRNLQESEEEEVPQESWDEGYSTLSIPPEMLASYKSYSGTFHSLEEQQVCMAVDIGGHRWDQVKKEDQEATGPRLSRELLDEKGPEVLQDSLDRCYSTPSGYLELTDSCQPYRSAFYILEQQRVGWALDMDEIEKYQEVEEDQDPSCPRLSRELLEAVEPEVLQDSLDRCYSTPSSCLEQPDSCLPYGSSFYALEEKHVGFSLDVGEIEKKGK | chr1(-):16564898,16564918,16565633,16565805,16566408,16566459,16567179,16567351,16567979,16568030,16569073,16569236,16573142,16573193,16574487,16574692,16575157,16575229,16576267,16576481,16577317,16578229,16584513,16584701 |
teRNA_161.3 | - | Intergenic | Non-coding | Non-coding | chr1(-):16578209,16578229,16584513,16584701 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.